Dec 09,2024

The American Diabetes Association Releases Standards of Care in Diabetes -2025

The American Diabetes Association (ADA) has published its Standards of Care in Diabetes 2025, offering evidence-based guidelines for diagnosing, managing, and preventing diabetes and prediabetes. Key updates include expanded recommendations for continuous glucose monitoring (CGM) for type 2 diabetes, guidance on GLP-1 receptor agonists for heart and kidney health, and addressing medication shortages. The guidelines also emphasize improved approaches to nutrition, weight management, and mental health screening for people with diabetes. Endorsed by leading medical societies, the 2025 Standards aim to enhance outcomes for people with diabetes. Resources like a mobile app and CE-accredited materials are available to support healthcare professionals in delivering optimal care.

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 10,2024

Stiftung Warentest awards Beurer GL 48 with a grade of 1.8

The Beurer blood glucose meter GL 48 mg/dL and the product-like variant GL 48 mmol/L have been awarded the grade „GUT" (1.8) by Stiftung Warentest in the current issue 11/2024. The independent consumer organization tested a total of 11 blood glucose meters and checked, among other things, the accuracy of blood sugar measurement, handling, technology and basic protection of personal data. The Beurer blood glucose meter GL 48 impressed in these categories and thus secured the quality rating „GUT" (1.8).

#bgm

View Analyst & Ambassador Comments
Go to original news
Dec 11,2024

India Diabetes Care Market Report 2024: Focus on Digital Health Solutions and Telemedicine, Personalized Medicine and Data Analytics

The Indian Diabetes Care Market, valued at USD 15.01 billion in 2024, is projected to grow at a CAGR of 6.18%, reaching USD 21.56 billion by 2030. The rise is fueled by increasing diabetes prevalence, technological advancements, and greater health awareness. Key trends include the adoption of digital health solutions like telemedicine and mobile health apps, which enhance accessibility and patient engagement, particularly in rural areas. Personalized medicine, driven by AI and data analytics, is also transforming care, enabling tailored treatment plans and improved outcomes.

#telehealth

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 04,2024

United Kingdom Diabetes Device Market Forecast Report 2024-2032

The UK Diabetes Device Market is expected to grow from $1.05 billion in 2023 to $2 billion by 2032 at a 7.35% CAGR. This growth is fueled by rising diabetes prevalence, government support for advanced technologies, and an aging population needing better management solutions. Innovations in continuous glucose monitors (CGMs) and insulin pumps are enhancing patient care, while initiatives like updated NICE guidelines expand access to automated monitoring devices for children. Major players include Abbott, Roche, Medtronic, and Dexcom.

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 05,2024

Growth Trends in the Insulin Biosimilar Market, Forecast to 2034

The global insulin biosimilar market is projected to grow from $500 million in 2023 to $2.25 billion by 2034, with a CAGR of 14.67%. This growth is driven by the rising prevalence of diabetes, technological advancements, and supportive government policies encouraging biosimilar adoption. Long-acting insulin analogs currently dominate the market due to their convenient dosing, while rapid-acting analogs and insulin pumps are expected to grow at the fastest rates. Injectable pens remain the top mode of administration due to ease of use and adherence, and hospital pharmacies lead in distribution channels. North America holds the largest market share, while the Asia-Pacific region is expected to grow rapidly due to improving healthcare infrastructure and awareness about diabetes management.

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Dec 04,2024

Google on AI in healthcare

Sunny Virmani, group product manager of health AI at Google, discusses expanding access to AI models for diabetic retinopathy in India and Thailand, AI’s potential to transform healthcare and Google’s plans for AI in healthcare in 2025.

View Analyst & Ambassador Comments
Go to original news
Nov 27,2024

[Latest] Global Point of Care Glucose Testing Market Size/Share Worth USD 5,455.3 Million by 2033 at a 4.5% CAGR

The global Point-of-Care (POC) glucose testing market is expected to grow from USD 3.51 billion in 2023 to USD 5.46 billion by 2033, with a CAGR of 4.5%. Key factors driving this growth include the rising prevalence of diabetes, advancements in glucose monitoring technologies, and an increased shift towards self-monitoring and homecare settings. The integration of digital health solutions, such as continuous glucose monitoring (CGM) systems and mobile applications, is also enhancing data management and improving patient outcomes. Additionally, public health initiatives and the aging population are contributing to the rising demand for POC glucose testing devices.

View Analyst & Ambassador Comments
Go to original news
Nov 28,2024

United States Diabetes Device Market Forecast Report 2024-2032: Economic Burden of Diabetes Soars to $412.9 Billion, Underlining Need for Effective Management Solutions

The U.S. diabetes device market is expected to grow from USD 8.67 billion in 2023 to USD 16.25 billion by 2032, with a compound annual growth rate (CAGR) of 7.23%. This growth is driven by the rising prevalence of diabetes, particularly type 2 diabetes, fueled by obesity, unhealthy lifestyle choices, and an aging population. As diabetes cases continue to increase, there is a growing demand for effective management devices. In addition, the economic burden of diabetes, with an estimated cost of USD 412.9 billion in 2022, further underscores the need for advanced diabetes care solutions. The rise in both diagnosed and undiagnosed diabetes cases in the U.S. is contributing to the expansion of the diabetes device market.

View Analyst & Ambassador Comments
Go to original news
Nov 27,2024

High Pressure League Certified App „beurer HealthManager Pro“

The health monitoring app „beurer HealthManager Pro" has been officially certified as a digital health helper by the German High Pressure League. The app is one of only four apps to receive this certification in the „Tested Apps for Hypertensioners" section. The award shows Beurer's leading position in the area of digital health solutions. The „beurer HealthManager Pro" stands for modern health management and combines health parameters such as blood sugar, blood pressure, weight, oxygen saturation, activity and temperature in an innovative platform. The specially developed app enables users to keep an eye on health values at any time and anywhere. Thanks to simple operation and certified data security by TÜV, the system offers a reliable basis for an independent lifestyle and a deep insight into your own health data.

View Analyst & Ambassador Comments
Go to original news
Nov 27,2024

Canada Diabetes Devices Market Forecast Report and Company Analysis 2024-2032

The Canada Diabetes Devices Market is projected to grow from US$ 736.5 million in 2023 to US$ 1.38 billion by 2032, with a CAGR of 7.27% from 2024 to 2032. This growth is driven by the increasing prevalence of diabetes, heightened public awareness, and advancements in technology, particularly in insulin delivery systems, continuous glucose monitors, and other glucose monitoring devices. The aging population, sedentary lifestyles, and unhealthy diets contribute to the rising incidence of diabetes in Canada. Government programs and supportive measures also play a role in driving the demand for more effective, personalized diabetes care solutions. As technology advances, user-friendly devices are improving patient outcomes and fueling further market growth.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES